Pluriomics is Therapeutic Devices in Netherlands that focus on drug efficacy screening business. They cover business area such as developer, human iPSC-derive cardiomyocyte, efficient and reliable safety pharmacology testing, cardiovascular drug efficacy, screening, well-define, serum-free medium, function, innovative technology, order, house, drug safety, medical practitioner, decision-making, attrition rate, an alternative, animal testing.
-
Drug Efficacy Screening
-
Biopartner building 3
Galileiweg 8
2333 BD Leiden
Netherlands
Private
developerhuman iPSC-derive cardiomyocyteefficient and reliable safety pharmacology testingcardiovascular drug efficacyscreeningwell-define, serum-free mediumfunctioninnovative technologyorderhousedrug safetymedical practitionerdecision-makingattrition ratean alternativeanimal testing
* We use standard office opening hours in near Pluriomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pluriomics is Therapeutic Devices business from Netherlands that founded in - ( years old in ), Pluriomics business is focusing on Drug Efficacy Screening.
Pluriomics headquarter office and corporate office address is located in Biopartner building 3 Galileiweg 8 2333 BD Leiden Netherlands.
Pluriomics was founded in Netherlands.
In , Pluriomics is currently focus on drug efficacy screening sector.
Above is snippet of Google Trends for "drug efficacy screening" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pluriomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.